Key result
Pharmacological management of advanced HF remains challenging due to frequent patient exclusion from clinical trials.
Why the study?
Managing advanced heart failure with persistent limiting symptoms and recurrent hospitalizations is challenging, as these patients often have characteristics that exclude them from most clinical studies.
Highlights the complexities and challenges of pharmacological management in patients with advanced heart failure who are often excluded from clinical trials.
Advanced HF pharmacotherapy requires cautious individualized use outside trial data; leaves open inclusive studies in complex patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fernanda Scussel (2022) conducted a review in Advanced Heart Failure. Pharmacological Treatment was evaluated. Pharmacological treatment of advanced heart failure presents significant management challenges due to complex patient characteristics that frequently exclude them from clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: